BlueRock Therapeutics Appoints Emile Nuwaysir President and CEO

17:22 EDT 30 Jun 2017 | Xconomy

Emile Nuwaysir has been named president and CEO of BlueRock Therapeutics. BlueRock, which spreads its operations across sites in Boston, New York, and Toronto, is developing a way to repair heart muscle by using stem cells. Nuwaysir was previously president and chief operating officer of Cellular Dynamics International, where his responsibilities included managing the company’s […]

Original Article: BlueRock Therapeutics Appoints Emile Nuwaysir President and CEO


More From BioPortfolio on "BlueRock Therapeutics Appoints Emile Nuwaysir President and CEO"

Quick Search


Relevant Topics

Cardiology is a specialty of internal medicine.  Cardiac electrophysiology : Study of the electrical properties and conduction diseases of the heart. Echocardiography : The use of ultrasound to study the mechanical function/physics of the h...

Arthritis Fibromyalgia Gout Lupus Rheumatic Rheumatology is the medical specialty concerned with the diagnosis and management of disease involving joints, tendons, muscles, ligaments and associated structures (Oxford Medical Diction...

Stem Cells
Track and monitor developments in stem cell research and commercial development.  Follow the tabs above to read the latest global news, research, clinical trials on stem cells and follow companies active in the stem cell industry.  BioPort...